Related Experiment Video

Updated: Aug 22, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

COX-2 inhibition and cancer: experimental findings and clinical correlates

Elizabeth Gail Roberts1, Linda Vona-Davis, Dale R Riggs

  • 1West Virginia University School of Medicine, Morgantown, USA.

The West Virginia Medical Journal
|September 24, 2004
PubMed

Insights

Cyclooxygenase-2 (COX-2) inhibitors significantly reduced breast and prostate cancer cell growth in laboratory tests. Rofecoxib also induced apoptosis in breast cancer cells, suggesting potential therapeutic applications.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Cyclooxygenase-2 (COX-2) is implicated in cancer development and progression.
  • Targeting COX-2 is a potential strategy for cancer therapy.

Purpose of the Study:

  • To investigate the in vitro efficacy of COX-2 inhibitors on breast and prostate cancer cell growth.
  • To determine if rofecoxib and NS398 inhibit proliferation and induce apoptosis in cancer cell lines.

Main Methods:

  • Treatment of human breast (MCF-7, ZR75-1) and prostate (PC-3, DU145) cancer cell lines with rofecoxib or NS398.
  • Cell viability assessed using MTT assay at 24 and 72 hours.
  • Statistical analysis performed using ANOVA.

Main Results:

  • Significant dose-dependent growth inhibition observed across all tested cancer cell lines (p < 0.05).
  • Rofecoxib demonstrated significant induction of apoptosis in breast cancer cells (p < 0.001).

Conclusions:

  • COX-2 inhibition effectively reduces the in vitro growth of human breast and prostate cancer cells.
  • Further clinical investigation is warranted to explore the therapeutic potential of rofecoxib in breast and prostate cancers.

More Related Videos

Establishment of Coloproctitis Cancer Model in Mice and Evaluation of Therapeutic Effect of Chinese Medicine06:24

Establishment of Coloproctitis Cancer Model in Mice and Evaluation of Therapeutic Effect of Chinese Medicine

Published on: October 13, 2023

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...